Why Genomics Media Group Exists

Dear Community,

I'm Meg Samek-Smith, co-founder, CEO, and Editor-in-Chief of Genomics Media Group (GMG). Over the past several years, I’ve had the privilege of working in the genomics world—on both the lab side and in developing an RNA and AI-enable screening tool. I've seen genomics' incredible potential and felt the frustration: the disconnect between what's good for people, what's good for business, and the processes that slow everything down—reimbursement, regulation, infrastructure, and doubt.

It's been over twenty years since the Human Genome Project finished (final edits in 2022). By now, genomics should be reshaping the world. Instead, most people still see it as science—not an economic story.

Genomics has hit its inflection point. Products are launching, platforms are scaling, and new markets are emerging across healthcare, agriculture, consumer goods, and AI-driven biology. Yet investors, operators, and many scientists still struggle to see how these breakthroughs connect into a coherent business landscape. The science is real. The companies are real. The capital is here.

That's why we built GMG—to be the "Bloomberg of Genomics," telling the business story of this emerging economy.

We publish news, analysis, and perspective. Through our podcast, The Helix Exchange, we spotlight the people turning DNA insights into products, companies, and markets. Our mission is simple: connect investors, entrepreneurs, and industry leaders with the breakthroughs and builders shaping the genomics economy.

We focus on six sectors where genomics is already creating measurable economic impact:

1.       Precision Medicine – therapeutics and diagnostics tailored to your DNA

2.       Enhanced Humanity – longevity, performance, cognitive optimization

3.       Organs – bioengineered tissues, transplants, regeneration

4.       Plants/Agribusiness – crops, soil health, sustainable farming

5.       Animals/Veterinary – companion animals, livestock, conservation

6.       Regenerative Medicine – stem cells, tissue repair, anti-aging

These areas are grounded in credible science and backed by emerging commercial models. Our content showcases the breakthroughs, companies, and people shaping these fields—helping you understand where to participate in this new economy.

We promise to be provocative yet scientifically grounded, ethical yet ambitious. We highlight genomics' potential to better humanity while providing actionable insights for business and investment.

Thank you for joining us. I look forward to connecting with our you as we explore this extraordinary frontier together.

Follow and subscribe: @genomicsmedia

Meg Samek-Smith

Co-Founder, CEO and Editor-in-Chief

Genomics Media Group